APOB and chronic kidney disease: Having successfully sub-fractionated and identified apoB100 and the lipid sub-fractions of the isolated LDL, indicatively, from patients with CKD-5d, we evaluate on them (before and after their hemodialysis and versus controls) the levels of six indicative oxidative modifications (among others, Figure 1) as characteristic of oxLDL status.